These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 20377469

  • 1. Faecal calprotectin in children with clinically quiescent inflammatory bowel disease.
    Sipponen T, Kolho KL.
    Scand J Gastroenterol; 2010 Aug; 45(7-8):872-7. PubMed ID: 20377469
    [Abstract] [Full Text] [Related]

  • 2. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB, Terrin G, Rapacciuolo L, Miele E, Siani MC, Puzone C, Cosenza L, Staiano A, Troncone R.
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [Abstract] [Full Text] [Related]

  • 3. Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.
    Kolho KL, Raivio T, Lindahl H, Savilahti E.
    Scand J Gastroenterol; 2006 Jun; 41(6):720-5. PubMed ID: 16716972
    [Abstract] [Full Text] [Related]

  • 4. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP, McNicholl AG.
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice.
    Berni Canani R, Rapacciuolo L, Romano MT, Tanturri de Horatio L, Terrin G, Manguso F, Cirillo P, Paparo F, Troncone R.
    Dig Liver Dis; 2004 Jul; 36(7):467-70. PubMed ID: 15285526
    [Abstract] [Full Text] [Related]

  • 6. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

  • 7. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, Ricchiuti A, Marchi S, Bottai M.
    Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
    [Abstract] [Full Text] [Related]

  • 8. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
    Van de Vijver E, Schreuder AB, Cnossen WR, Muller Kobold AC, van Rheenen PF, North Netherlands Pediatric IBD Consortium.
    Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
    [Abstract] [Full Text] [Related]

  • 9. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease.
    Fagerberg UL, Lööf L, Lindholm J, Hansson LO, Finkel Y.
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):414-20. PubMed ID: 18030206
    [Abstract] [Full Text] [Related]

  • 10. Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
    Laharie D, Mesli S, El Hajbi F, Chabrun E, Chanteloup E, Capdepont M, Razaire S, de Lédinghen V, Zerbib F.
    Aliment Pharmacol Ther; 2011 Aug; 34(4):462-9. PubMed ID: 21671970
    [Abstract] [Full Text] [Related]

  • 11. [Faecal calprotectin in inflammatory bowel diseases: review].
    Kallel L, Fekih M, Boubaker J, Filali A.
    Tunis Med; 2011 May; 89(5):425-9. PubMed ID: 21557177
    [Abstract] [Full Text] [Related]

  • 12. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 13. Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.
    Sipponen T, Björkesten CG, Färkkilä M, Nuutinen H, Savilahti E, Kolho KL.
    Scand J Gastroenterol; 2010 Mar; 45(3):325-31. PubMed ID: 20034360
    [Abstract] [Full Text] [Related]

  • 14. Age-related faecal calprotectin, lactoferrin and tumour M2-PK concentrations in healthy volunteers.
    Joshi S, Lewis SJ, Creanor S, Ayling RM.
    Ann Clin Biochem; 2010 May; 47(Pt 3):259-63. PubMed ID: 19740914
    [Abstract] [Full Text] [Related]

  • 15. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
    Leach ST, Yang Z, Messina I, Song C, Geczy CL, Cunningham AM, Day AS.
    Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869
    [Abstract] [Full Text] [Related]

  • 16. Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis.
    Johnson MW, Maestranzi S, Duffy AM, Dewar DH, Forbes A, Bjarnason I, Sherwood RA, Ciclitira P, Nicholls JR.
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):174-9. PubMed ID: 18301296
    [Abstract] [Full Text] [Related]

  • 17. Faecal calprotectin -- a useful tool in the management of inflammatory bowel disease.
    Burri E, Beglinger C.
    Swiss Med Wkly; 2012 Mar; 142():w13557. PubMed ID: 22481443
    [Abstract] [Full Text] [Related]

  • 18. [Measurement of calprotectin in faeces].
    Jahnsen J, Røseth AG, Aadland E.
    Tidsskr Nor Laegeforen; 2009 Apr 16; 129(8):743-5. PubMed ID: 19373299
    [Abstract] [Full Text] [Related]

  • 19. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study.
    Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, Karoui S, Zouari B, Boubaker J, Kaabachi N, Filali A.
    Eur J Gastroenterol Hepatol; 2010 Mar 16; 22(3):340-5. PubMed ID: 19581809
    [Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory effect of biological treatment in patients with inflammatory bowel diseases: calprotectin and IL-6 changes do not correspond to sRAGE changes.
    Malícková K, Kalousová M, Fucíková T, Bortlík M, Duricová D, Komárek V, Zima T, Janatková I, Lukás M.
    Scand J Clin Lab Invest; 2010 Jul 16; 70(4):294-9. PubMed ID: 20446880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.